Features of subsyndromal and persistent delirium

Br J Psychiatry. 2012 Jan;200(1):37-44. doi: 10.1192/bjp.bp.111.095273. Epub 2011 Nov 10.

Abstract

Background: Longitudinal studies of delirium phenomenology are lacking.

Aims: We studied features that characterise subsyndromal delirium and persistent delirium over time.

Method: Twice-weekly evaluations of 100 adults with DSM-IV delirium using the Delirium Rating Scale-Revised-98 (DRS-R98) and Cognitive Test for Delirium (CTD). The generalised estimating equation method identified symptom patterns distinguishing full syndromal from subsyndromal delirium and resolving from persistent delirium.

Results: Participants (mean age 70.2 years (s.d. = 10.5)) underwent 323 assessments (range 2-9). Full syndromal delirium was significantly more severe than subsyndromal delirium for DRS-R98 thought process abnormalities, delusions, hallucinations, agitation, retardation, orientation, attention, and short- and long-term memory items, and CTD attention, vigilance, orientation and memory. Persistent full syndromal delirium had greater disturbance of DRS-R98 thought process abnormalities, delusions, agitation, orientation, attention, and short- and long-term memory items, and CTD attention, vigilance and orientation.

Conclusions: Full syndromal delirium differs from subsyndromal delirium over time by greater severity of many cognitive and non-cognitive symptoms. Persistent delirium involves increasing prominence of recognised core diagnostic features and cognitive impairment.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Algorithms
  • Benzodiazepines / therapeutic use
  • Comorbidity
  • Delirium / diagnosis*
  • Delirium / epidemiology
  • Delirium / physiopathology*
  • Dementia / epidemiology*
  • Diagnostic and Statistical Manual of Mental Disorders
  • Disease Progression
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Models, Statistical
  • Neuropsychological Tests
  • Palliative Care*
  • Prospective Studies
  • Severity of Illness Index
  • Syndrome

Substances

  • Benzodiazepines